Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2013 Dec;98(6):1564-74.
doi: 10.3945/ajcn.113.061432. Epub 2013 Oct 9.

The association between MTHFR 677C>T genotype and folate status and genomic and gene-specific DNA methylation in the colon of individuals without colorectal neoplasia

Affiliations
Clinical Trial

The association between MTHFR 677C>T genotype and folate status and genomic and gene-specific DNA methylation in the colon of individuals without colorectal neoplasia

Joanna Hanks et al. Am J Clin Nutr. 2013 Dec.

Abstract

Background: Decreased genomic and increased gene-specific DNA methylation predispose to colorectal cancer. Dietary folate intake and the methylenetetrahydrofolate reductase polymorphism (MTHFR 677C>T) may influence risk by modifying DNA methylation.

Objective: We investigated the associations between MTHFR 677C>T genotype, folate status, and DNA methylation in the colon.

Design: We conducted a cross-sectional study of 336 men and women (age 19-92 y) in the United Kingdom without colorectal neoplasia. We obtained blood samples for measurement of serum and red blood cell folate, plasma homocysteine, and MTHFR 677C>T genotype and colonic tissue biopsies for measurement of colonic tissue folate and DNA methylation (genomic- and gene-specific, estrogen receptor 1, ESR1; myoblast determination protein 1, MYOD1; insulin-like growth factor II, IGF2; tumor suppressor candidate 33, N33; adenomatous polyposis coli, APC; mut-L homolog 1, MLH1; and O(6)-methylguanine-DNA methyltransferase, MGMT) by liquid chromatography/electrospray ionization mass spectrometry and pyrosequencing, respectively.

Results: Of the 336 subjects recruited, 185 (55%) carried the CC, 119 (35%) the CT, and 32 (10%) the TT alleles. No significant differences in systemic markers of folate status and colonic tissue folate between genotypes were found. The MTHFR TT genotype was not associated with genomic or gene-specific DNA methylation. Biomarkers of folate status were not associated with genomic DNA methylation. Relations between biomarkers of folate status and gene-specific methylation were inconsistent. However, low serum folate was associated with high MGMT methylation (P = 0.001).

Conclusion: MTHFR 677C>T genotype and folate status were generally not associated with DNA methylation in the colon of a folate-replete population without neoplasia.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Genomic DNA methylation by MTHFR 677C>T genotype. Bars represent means and 95% CIs for unadjusted values (CC, n = 185; CT, n = 119; TT, n = 32; P = 0.60). P = 0.60 for comparison between genotypes (ANOVA).
FIGURE 2.
FIGURE 2.
Gene-specific DNA methylation by MTHFR 677C>T genotype. Boxes represent medians and IQRs; whiskers are the expected range and outliers. A: ESR1, N33, MYOD1, and IGF2 methylation. B: APC, MGMT, and MLH1 methylation (CC, n = 185; CT, n = 119; TT, n = 32). Kruskal-Wallis tests were used for comparison between genotypes (ESR1, P = 0.92; N33, P = 0.12; MYOD1, P = 0.24; IGF2, P = 0.77; APC, P = 0.45; MGMT, P = 0.68; MLH1, P = 0.89).
FIGURE 3.
FIGURE 3.
Association between gene-specific methylation in colonic mucosa, biomarkers of folate status, and MTHFR 677C>T genotype. Dots and horizontal lines represent the coefficients and 95% CIs, respectively, obtained from generalized linear models adjusted for age, sex (male or female), ethnicity (white or nonwhite), supplement use (user or nonuser), serum vitamin B-12, and MTHFR 677C>T genotype. The coefficients give the amount of change in the log odds of having high methylation in each gene investigated for each unit increase in the independent variables (with all other variables held constant) serum folate (nmol/L) (A), red blood cell folate (nmol/L) (B), tissue folate (nmol/g tissue) (C), and plasma homocysteine (μmol/L) (D) or the log odds of having high methylation in individuals carrying the MTHFR CT genotype (E) or TT genotype (F) compared with individuals carrying the CC genotype. The vertical dotted line (coefficient of 0) shows the line of no effect. Coefficients >0 indicate an increased odds of having high methylation (positive association), whereas coefficients <0 indicate a decreased odds of having high methylation (negative association), for each unit increase in biomarker concentrations, or for the CT or TT genotype compared with the CC genotype (reference). The threshold for significance with Bonferroni correction for 8 repeated tests is P = 0.006. 1P = 0.001 (significant after Bonferroni correction); 2P = 0.04; 3P = 0.01; 4P = 0.02; 5P = 0.02; 6P = 0.02.

References

    1. Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, Nickel C, Koren G. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol 2011;35:2–10. - PubMed
    1. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005;113:825–8. - PubMed
    1. Kim DH, Smith-Warner SA, Spiegelman D, Yaun SS, Colditz GA, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Harnack L, et al. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 2010;21:1919–30. - PMC - PubMed
    1. Gibson TM, Weinstein SJ, Pfeiffer RM, Hollenbeck AR, Subar AF, Schatzkin A, Mayne ST, Stolzenberg-Solomon R. Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr 2011;94:1053–62. - PMC - PubMed
    1. Stevens VL, McCullough ML, Sun J, Jacobs EJ, Campbell PT, Gapstur SM. High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology 2011;141:98–105. - PubMed

Publication types

MeSH terms

Associated data